Stanley Wong

Stanley Wong

Auto-generated profile, based on publicly available information

Stanley Wong

British Columbia Centre for Disease Control 2 , Vancouver, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
NJNaveed Zafar Janjua
Naveed Zafar Janjua
SWStanley Wong
Stanley Wong
YAYounathan Abdia
Younathan Abdia
DJDahn Jeong
Dahn Jeong
TBTerri Buller-Taylor
Terri Buller-Taylor
MKMel Krajden
Mel Krajden

24 August 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
PAPrince A Adu
Prince A Adu
MBMawuena Binka
Mawuena Binka
BMBushra Mahmood
Bushra Mahmood
DJDahn Jeong
Dahn Jeong
TBTerri Buller-Taylor
Terri Buller-Taylor
NJNaveed Zafar Janjua
Naveed Zafar Janjua
Purpose Several non-pharmaceutical interventions, such as physical distancing, handwashing, self-isolation, and school and business closures, were implemented in British Columbia (BC) following the first laboratory-confirmed case of COVID-19 on 26 January 2020, to minimise in-person contacts that could spread infections. The BC COVID-19 Population Mixing Patterns Survey (BC-Mix) was established as a surveillance system to measure behaviour and contact patterns in BC over time to inform the timing of the easing/re-imposition of control measures. In this paper, we describe the BC-Mix survey design and the demographic characteristics of respondents. Participants The ongoing repeated online survey was launched in September 2020. Participants are mainly recruited through social media platforms (including Instagram, Facebook, YouTube, WhatsApp). A follow-up survey is sent to participants 2–4 weeks after completing the baseline survey. Survey responses are weighted to BC’s population by age, sex, geography and ethnicity to obtain generalisable estimates. Additional indices such as the Material and Social Deprivation Index, residential instability, economic dependency, and others are generated using census and location data. Findings to date As of 26 July 2021, over 61 000 baseline survey responses were received of which 41 375 were eligible for analysis. Of the eligible participants, about 60% consented to follow-up and about 27% provided their personal health numbers for linkage with healthcare databases. Approximately 83.5% of respondents were female, 58.7% were 55 years or older, 87.5% identified as white and 45.9% had at least a university degree. After weighting, approximately 50% were female, 39% were 55 years or older, 65% identified as white and 50% had at least a university degree. Future plans Multiple papers describing contact patterns, physical distancing measures, regular handwashing and facemask wearing, modelling looking at impact of physical distancing measures and vaccine acceptance, hesitancy and uptake are either in progress or have been published.

1 August 2018 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
Zahid ButtZahid Butt
Zahid Butt
NSNabin Shrestha
Nabin Shrestha
DGDionne Gesink
Dionne Gesink
MMMichelle Murti
Michelle Murti
JBJane Buxton
Jane Buxton
NJNaveed Zafar Janjua
Naveed Zafar Janjua
Background: Understanding differences in HIV incidence among people living with hepatitis C virus (HCV) can help inform strategies to prevent HIV infection. We estimated the time to HIV diagnosis among HCV-positive individuals and evaluated factors that could affect HIV-infection risk in this population. Patients and methods: The British Columbia Hepatitis Testers Cohort includes all BC residents (~1.5 million: about a third of all residents) tested for HCV and HIV from 1990 to 2013 and is linked to administrative health care and mortality data. All HCV-positive and HIV-negative individuals were followed to measure time to HIV acquisition (positive test) and identify factors associated with HIV acquisition. Adjusted HRs (aHRs) were estimated using Cox proportional-hazard regression. Results: Of 36,077 HCV-positive individuals, 2,169 (6%) acquired HIV over 266,883 years of follow-up (overall incidence of 8.1 per 1,000 person years). Overall median (IQR) time to HIV infection was 3.87 (6.06) years. In Cox regression, injection-drug use (aHR 1.47, 95% CI 1.33–1.63), HBV infection (aHR 1.34, 95% CI 1.16–1.55), and being a man who has sex with men (aHR 2.78, 95% CI 2.14–3.61) were associated with higher risk of HIV infection. Opioid-substitution therapy (OST) (aHR 0.59, 95% CI 0.52–0.67) and mental health counseling (aHR 0.48, 95% CI 0.43–0.53) were associated with lower risk of HIV infection. Conclusion: Injection-drug use, HBV coinfection, and being a man who has sex with men were associated with increased HIV risk and engagement in OST and mental health counseling were associated with reduced HIV risk among HCV-positive individuals. Improving access to OST and mental health services could prevent transmission of HIV and other blood-borne infections, especially in settings where access is limited.

26 November 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
RMRichard L. Morrow
Richard L. Morrow
JMJean D Makuza
Jean D Makuza
DJDahn Jeong
Dahn Jeong
MIMike Irvine
Mike Irvine
BSBeate H Sander
Beate H Sander
NJNaveed Zafar Janjua
Naveed Zafar Janjua
Background: Previous research suggests the COVID-19 pandemic was associated with reductions in HBV testing early in the pandemic. However, impacts of the pandemic on HBV testing in the longer-term and among people who inject drugs (PWID) are unclear. We investigated the impact of the pandemic and related policies on HBV testing from 2020 to 2022, including among PWID, in British Columbia (BC), Canada. Methods: Using population data from the BC COVID-19 Cohort, we conducted interrupted time series analyses of HBV surface antigen (HBsAg), HBV DNA, and HBV e-antigen (HBeAg) testing. The study included a prepandemic period (January 2017–February 2020), a transition period (March–May 2020), and pandemic periods in 2020 (June–December), 2021, and 2022. Results: HBsAg testing decreased by 16.5% (95% CI 13.9–18.9) and HBV DNA testing decreased by 11.6% (95% CI 9.5–13.6) in June–December 2020 relative to predicted levels, and testing remained lower than predicted throughout 2021 and 2022. Percentage reductions in HBV DNA testing were greater for PWID compared with non-PWID in 2020 (30.0% vs 11.2%) and thereafter. Changes in HBeAg testing overall were less pronounced but varied by sex and age. Conclusions: The pandemic and related policies were associated with decreases in HBsAg and HBV DNA testing in 2020, and testing remained lower than predicted throughout 2021 and 2022. Additional efforts to increase HBV testing are needed, including strategies to ensure linkage to care for PWID.

11 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PAPrince Adu
Prince Adu
MBMawuena Binka
Mawuena Binka
BMBushra Mahmood
Bushra Mahmood
DJDahn Jeong
Dahn Jeong
TBTerri Buller-Taylor
Terri Buller-Taylor
NJNaveed Zafar Janjua
Naveed Zafar Janjua
Introduction Several non-pharmaceutical interventions such as physical distancing, hand washing, self-isolation, and schools and business closures, were implemented in British Columbia (BC) following the first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) on January 26, 2020, to minimize in-person contacts that could spread infections. The BC COVID-19 Population Mixing Patterns survey (BC-Mix) was established as a surveillance system to measure behaviour and contact patterns in BC over time to inform the timing of the easing/re-imposition of control measures. In this paper, we describe the BC-Mix survey design and the demographic characteristics of respondents. Methods The ongoing repeated online survey was launched in September 2020. Participants are mainly recruited through social media platforms (including Instagram, Facebook, YouTube, WhatsApp). A follow up survey is sent to participants two to four weeks after completing the baseline survey. Survey responses are weighted to BC’s population by age, sex, geography, and ethnicity to obtain generalizable estimates. Additional indices such as the material and social deprivation index, residential instability, economic dependency, and others are generated using census and location data. Results As of July 26, 2021, over 61,000 baseline survey responses were received of which 41,375 were eligible for analysis. Of the eligible participants, about 60% consented to follow up and about 27% provided their personal health numbers for linkage with healthcare databases. Approximately 50% of respondents were female, 39% were 55 years or older, 65% identified as white and 50% had at least a university degree. Conclusion The pandemic response is best informed by surveillance systems capable of timely assessment of behaviour patterns. BC-Mix survey respondents represent a large cohort of British Columbians providing near real-time information on behavioural and contact patterns in BC. Data from the BC-Mix survey would inform provincial COVID-19-related control measures.

23 January 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
AGAmit K. Gupta
Amit K. Gupta
AAAidan Ablona
Aidan Ablona
TCTheodora B. Consolacion
Theodora B. Consolacion
SBSofia Bartlett
Sofia Bartlett
SBScott Beck
Scott Beck
TGTroy Grennan
Troy Grennan
Background: Anal squamous cell carcinoma caused by human papillomavirus disproportionately affects people living with human immunodeficiency virus (HIV; PLWH), particularly gay, bisexual, and other men who have sex with men (GBM). New guidelines recommend screening and treatment of precancerous lesions. We aimed to estimate anal cancer incidence by HIV status, sex, and GBM status in British Columbia, Canada. Methods: Using administrative health databases, we assessed anal cancer stratified by HIV status, sex, and sexual orientation from 1990 to 2019. A phenotypic algorithm was used to classify GBM status. We evaluated the comparative incidence of anal cancer using Fine and Gray’s competing risks subdistribution hazards model. Hazard ratios (HR) were estimated and adjusted for age, healthcare utilization, urbanicity, and Charlson comorbidity index. Results: Among 571 anal cancer diagnoses assessed, the incidence was highest among GBM with HIV [78.09 per 100,000 person-years (PY); 95% confidence interval (CI), 61.24–99.58], followed by heterosexual males with HIV (44.49 per 100,000 PY; 95% CI, 29.56–66.95) and females with HIV (12.05 per 100,000 PY; 95% CI, 4.52–32.11). GBM with HIV experience a 76-fold increased anal cancer risk compared with heterosexual men without HIV (adjusted HR 76.08; 95% CI, 55.14–104.97). Conclusions: There is an unmet need in anal cancer prevention among PLWH. Screening strategies that are sensitive, specific, acceptable, and cost-effective are necessary. Impact: This study provides the first population-based estimates of anal cancer incidence by HIV and GBM status in British Columbia, highlighting disparities and rising trends. These findings support prioritizing targeted screening programs and improving access to care.